 | Jacob Berger
Neurology
|
| | Andrew Blum
Neurology
My areas of research interest involve diverse aspects of clinical epilepsy, particularly psychiatric aspects of epilepsy (including diagnosis and treatment of non-epileptic seizures), hormonal interactions with AEDs, localization of epileptic foci (including radiologic strategies), and development and optimal use of anticonvulsant therapeutics. |
| | William Douglas Brown
Neurology
Pediatrics, Department of
|
| | Victoria Chang
Neurology
|
| | Jeannette Chirico-Post
Neurology
|
| | Lori Daiello
Neurology
Comprehensive knowledge of the comparative risks and benefits associated with the use or discontinuation of psychopharmacologic medications in patients with dementia and complex medical illness is often not possible due to the knowledge gaps that exist in the field of geriatric pharmacology. My research explores how medications affect the trajectory of decline in cognitive and functional abilities and the development of neuropsychiatric symptoms in progressive degenerative dementias. |
 | John E. Donahue
Pathology and Laboratory Medicine, Department of
Neurology
While there is a growing body of evidence to indicate that the blood-brain barrier (BBB) is compromised in Alzheimer's disease (AD), there has been little data to support a link between known risk factors for AD and the BBB. My research will attempt to show that the product of the ε4 allele of the APOE gene, a known risk factor for developing AD, somehow fails to maintain the integrity of the BBB, compared to the ε3 allele, and that this BBB failure leads to the chain of events resulting in AD. |
 | J. Donald Easton
Neurology
J. Donald Easton has research interests in antiplatelet agents in prevention of stroke and other vascular diseases, carotid artery surgery in stroke prevention, patent foramen ovale and stroke, and rimonabant in vascular diseases. |
| | Edward Feldmann
Neurology
Decision making in ultrasound of cerbrovascular diseases; acute stroke treatment (clinical trials), Cerebrovascular Disease |
 | Joseph Friedman
Neurology
I am interested in all aspects of movement disorders. I spend most of my time seeing patients with Parkinson's disease and other movement disorders and have research interests in behavioral aspects of Parkinson's disease, particularly drug induced psychosis and fatigue. I am also interested in Huntington's disease, Machado-Joseph disease (spino cerebellar ataxia type 3), episodic ataxia type 2, as well as drug induced movement disorders. |
| | John Gaitanis
Neurology
Pediatrics, Department of
General Neurology |
 | Generoso Gascon
Neurology
Pediatrics, Department of
|
| | Mason Gasper
Neurology
General Neurology |
| | Guy Geffroy
Neurology
General Neurology & Multiple Sclerosis |
 | James Gilchrist
Neurology
|
| | Norman Gordon
Neurology
|
| | Fred Griffith
Neurology
|
| | Gita Harappanahally
Neurology
Pediatrics, Department of
|
| | Chellani Harini
Neurology
Pediatrics, Department of
|
| | Jessie Jeyapalan
Neurology
|
| | Suriya Jeyapalan
Neurology
|
| | Gary Johnson
Neurology
|
| | Elena Kamenetsky
Neurology
|
| | Joel Kaufman
Neurology
|
| | Karen Kerman
Neurology
Pediatrics, Department of
|
 | W. Curt LaFrance Jr.
Psychiatry and Human Behavior, Department of
Neurology
W. Curt LaFrance, Jr. conducts clinical research in brain/behavior disorders, focusing on the neuropsychiatry of epilepsy and nonepileptic seizures. |
 | Albert Lo
Neurology
Community Health, Department of
Engineering, Division of
• Stroke rehabilitation Phase II/III Clinical Trials in Robotic Neurorehabilitation
• Multiple Sclerosis Clinical Pilot Studies Robotic Neurorehabilitation
• Neuroprotection in Multiple Sclerosis and animal models
• Investigations in Multiple Sclerosis Clinical Epidemiology
• Rhode Island Multiple Sclerosis Study (RIMMS)
• Mild traumatic brain injury: impact on attention, cognition and motor control |
| | Sydney Louis
Neurology
|
 | David Mandelbaum
Neurology
Pediatrics, Department of
Childhood epilepsy
cognitive aspects of epilepsy and anticonvulsant medications
neonatal neurology
neurological aspects of autism |
| | Michelle Mellion
Neurology
|
| | Stephen Mernoff
Neurology
|
| | Thomas Morgan
Neurology
|
| | Georg Noren
Neurology
|
 | Brian Ott
Neurology
My research focuses on developing new and effective treatments for Alzheimer's disease as well as studying the cognitive and behavioral disturbances seen in mild cognitive impairment and early dementia. Our center is a major national site for clinical trials of experimental drugs for the treatment of Alzheimer's disease. |
| | Tara Patterson
Neurology
|
| | N. Stevenson Potter
Neurology
Neurosurgery
|
| | Kenneth Rickler
Psychiatry and Human Behavior, Department of
Neurology
|
| | Syed Rizvi
Neurology
Multiple sclerosis and neuro-immunology
|
| | Julie Roth
Neurology
|
| | George Sachs
Neurology
|
 | Stephen Salloway
Neurology
Psychiatry and Human Behavior, Department of
My research focuses on the following areas: clinical trials for the prevention and treatment of Alzheimer's disease, mild cognitive impairment, and vascular dementia; studies of genetic and sporadic forms of microvascular brain disease; studies of executive function and frontal behaviors; and the development of imaging biomarkers to study conversion to dementia. |
 | Peter Snyder
Neurology
|
| | William Stone
Neurology
|
| | Erica Szabados
Neurology
|
| | Charlene Tate
Neurology
|
| | Bradford Thompson
Neurology
Neurosurgery
Dr. Thompson's research interests include outcomes analyses in patients suffering from a wide variety of neurocritical care diseases, including intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury. |
| | M. Howard Triedman
Neurology
|
| | Janet Wilterdink
Neurology
|
| | Israel Yaar
Neurology
|
| | Vladislav Zayas
Neurology
|
